1. Home
  2. Companies
  3. CMP
  4. Material Events

Compumedics (ASX:CMP) — Material Events

ASX:CMP · 12 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 2 articles Significant 10 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
10
Compumedics Surges with Record Sales and Profitable Growth in FY25Medium
Compumedics posts record FY25 sales, returns to profitability, and sets strong FY26 growth outlook
14 July 2025 ·Business Update ·85
Compumedics Accelerates Somfit D Rollout After Early FDA NodMedium
Compumedics raises $2.15M to accelerate Somfit D commercialisation after early FDA approval
15 Oct 2025 ·Capital Raising ·85
Compumedics Surges with 32% Revenue Growth and Returns to Profit in H1 FY26Medium
Compumedics posts 32% revenue growth and returns to profit in H1 FY26, driven by MEG and SaaS expansion
25 Feb 2026 ·Half-year financial report ·85
Compumedics Posts Record H1 Sales Orders, Eyes Stronger H2 with Somfit D LaunchMedium
Compumedics posts record H1 FY26 sales orders and 32% revenue growth, reaffirms FY26 guidance
22 Jan 2026 ·Business Update ·85
Compumedics Secures $4.2M MEG Order, Boosting $30M Contracted SalesMedium
Compumedics wins $4.2M MEG order in China, total MEG orders reach $30M
29 Jan 2026 ·Sales Order Announcement ·85
Compumedics Posts Record $60.3M FY26 Revenue with SaaS Growth Surging 70%Medium
Compumedics reports record FY26 revenue of $60.3 million with 70% SaaS growth and targets strong FY27 growth
6 July 2026 ·Business Update ·85
Compumedics Accelerates Growth with 22% Sales Surge Despite $1.3M LossMedium
Compumedics FY25 revenue rises 2%, sales orders up 22%, EBITDA grows 9%, but posts $1.3M net loss
27 Aug 2025 ·Appendix 4E - Final Report ·80
Compumedics Updates FY26 Guidance Amid MEG Delays, Eyes Stronger FY27 GrowthMedium
Compumedics updates FY26 guidance with strong order momentum despite timing delays; confident in FY27 growth
21 Apr 2026 ·Financial Update ·80
Compumedics Secures $4.9M MEG Order, Boosting China Sales to $25MMedium
Compumedics wins $4.9M MEG order from Beijing Normal University, total MEG sales reach $25M
10 Nov 2025 ·Sales Order Announcement ·80
Compumedics Locks In $24.4M China Deals with 10% Annual Growth TargetsMedium
Compumedics secures $24.4m four-year China distribution deals with 10% annual growth commitments
28 July 2025 ·Major Contract Announcement ·80
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.